These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9209568)

  • 21. How well do the ADAS-cog and its subscales measure cognitive dysfunction in Alzheimer's disease?
    Benge JF; Balsis S; Geraci L; Massman PJ; Doody RS
    Dement Geriatr Cogn Disord; 2009; 28(1):63-9. PubMed ID: 19641319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The episodic buffer and learning in early Alzheimer's disease.
    Germano C; Kinsella GJ; Storey E; Ong B; Ames D
    J Clin Exp Neuropsychol; 2008 Aug; 30(6):627-38. PubMed ID: 18612873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive approaches to early Alzheimer's disease diagnosis.
    Harrison J
    Med Clin North Am; 2013 May; 97(3):425-38. PubMed ID: 23642579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selected psychiatric symptoms associated with rate of cognitive decline in patients with Alzheimer's disease.
    Miller TP; Tinklenberg JR; Brooks JO; Fenn HH; Yesavage JA
    J Geriatr Psychiatry Neurol; 1993; 6(4):235-8. PubMed ID: 8251053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment.
    Fleisher AS; Sowell BB; Taylor C; Gamst AC; Petersen RC; Thal LJ;
    Neurology; 2007 May; 68(19):1588-95. PubMed ID: 17287448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The 5-word test in 37 depressed patients compared with 36 normal controls and 35 patients with mild Alzheimer's disease].
    Croisile B; Astier JL; Beaumont C; Mollion H
    Encephale; 2011 Apr; 37(2):127-32. PubMed ID: 21482230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early detection of isolated memory deficits in the elderly: the need for more sensitive neuropsychological tests.
    de Jager CA; Milwain E; Budge M
    Psychol Med; 2002 Apr; 32(3):483-91. PubMed ID: 11989993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Arabic Version of the Cognitive Subscale of the Alzheimer's Disease Assessment Scale (ADAS-Cog): Reliability, Validity, and Normative Data.
    Ben Jemaa S; Attia Romdhane N; Bahri-Mrabet A; Jendli A; Le Gall D; Bellaj T
    J Alzheimers Dis; 2017; 60(1):11-21. PubMed ID: 28505978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Alzheimer's Disease Assessment Scale: patterns and predictors of baseline cognitive performance in multicenter Alzheimer's disease trials.
    Doraiswamy PM; Bieber F; Kaiser L; Krishnan KR; Reuning-Scherer J; Gulanski B
    Neurology; 1997 Jun; 48(6):1511-7. PubMed ID: 9191757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic accuracy of percent retention scores on RBANS verbal memory subtests for the diagnosis of Alzheimer's disease and mild cognitive impairment.
    Clark JH; Hobson VL; O'Bryant SE
    Arch Clin Neuropsychol; 2010 Jun; 25(4):318-26. PubMed ID: 20378680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How Do Scores on the ADAS-Cog, MMSE, and CDR-SOB Correspond?
    Balsis S; Benge JF; Lowe DA; Geraci L; Doody RS
    Clin Neuropsychol; 2015; 29(7):1002-9. PubMed ID: 26617181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rate of cognitive change in Alzheimer's disease: methodological approaches using random effects models.
    Gould R; Abramson I; Galasko D; Salmon D
    J Int Neuropsychol Soc; 2001 Nov; 7(7):813-24. PubMed ID: 11771624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Verbal cued recall as a predictor of conversion to Alzheimer's disease in Mild Cognitive Impairment.
    Dierckx E; Engelborghs S; De Raedt R; Van Buggenhout M; De Deyn PP; Verté D; Ponjaert-Kristoffersen I
    Int J Geriatr Psychiatry; 2009 Oct; 24(10):1094-100. PubMed ID: 19280679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calculation and number processing in mild Alzheimer's disease.
    Deloche G; Hannequin D; Carlomagno S; Agniel A; Dordain M; Pasquier F; Pellat J; Denis P; Desi M; Beauchamp D
    J Clin Exp Neuropsychol; 1995 Aug; 17(4):634-9. PubMed ID: 7593481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Examining the reliability of ADAS-Cog change scores.
    Grochowalski JH; Liu Y; Siedlecki KL
    Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2016 Sep; 23(5):513-29. PubMed ID: 26708116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's disease.
    Gillen TE; Gregg KM; Yuan H; Kurth MC; Krishnan KR
    Psychopharmacol Bull; 2001; 35(2):83-96. PubMed ID: 12397889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of decline in Alzheimer's disease.
    Boller F; Becker JT; Holland AL; Forbes MM; Hood PC; McGonigle-Gibson KL
    Cortex; 1991 Mar; 27(1):9-17. PubMed ID: 2055046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation study of the Alzheimer's disease assessment scale-cognitive subscale (ADAS-Cog) for the Portuguese patients with mild cognitive impairment and Alzheimer's disease.
    Nogueira J; Freitas S; Duro D; Almeida J; Santana I
    Clin Neuropsychol; 2018; 32(sup1):46-59. PubMed ID: 29566598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brief recall tasks and memory assessment in Alzheimer's disease.
    Kaltreider LB; Cullum CM; Lacritz LH; Brewer K; Filley CM
    Appl Neuropsychol; 1999; 6(3):165-9. PubMed ID: 10497692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Executive function: the core feature of dementia?
    Voss SE; Bullock RA
    Dement Geriatr Cogn Disord; 2004; 18(2):207-16. PubMed ID: 15211077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.